Fennec Pharmaceuticals (RV41.F) Q1 2025 Earnings

10MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.2
-0.01
0.19
0.38

Details

Expected EPS
-0.11862602897192098
Actual EPS
-0.05550205178960099
Surprise EPS
0.06
Surprise Percent
+53.21%

Description

Fennec Pharmaceuticals (RV41.F) has reported earnings of -0.05550205178960099 per share for Q1 2025.

0 Comments

Share your thoughts